Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
LY2811376
Cat No.
CEI-1409
Product Overview
LY2811376 is a non-peptidic inhibitor of BACE1.Beta-secretase 1 (BACE1) is an aspartic-acid protease that cleaves the amyloid precursor protein (APP) into amyloid-β peptide (Aβ), which plays a critical role in Alzheimer's disease (AD). In recombinant enzyme assays, LY2811376 inhibited hBACE1 with IC50 values of 249 nM and 239 nM against a larger chimeric protein substrate and a small synthetic peptide, respectively. In a human embryonic kidney cell line overexpressed APP, LY2811376 decreased Aβ secretion with EC50 value of 300 nM in a concentration-dependant way. In SH-SY5Y cells, LY2811376 reduced Aβ 1-40 and Aβ 1-42 secreted to the cell medium while increased the level of Aβ 5-40. In the APPV717F mouse, LY2811376 significantly reduced Aβ, as well as sAPP and C99, the cleavage products of APP by BACE1.In a healthy population (n =18), LY2811376 (30 mg, 90 mg) increased Aβ 5-40 and Aβ 5-X in a dose-dependant way, while Aβ 1-34 reduced in a same way. These results suggested that LY2811376 inhibited N-terminally truncated Aβ peptides in a BACE1-independent pathway.
CAS No.
1194044-20-6
Molecular Weight
320.4
Purity
0.98
Storage
Store at -20°C
Targets
BACE1
Molecular Formula
C15H14F2N4S
Chemical Name
(4S)-4-(2,4-difluoro-5-pyrimidin-5-ylphenyl)-4-methyl-5,6-dihydro-1,3-thiazin-2-amine
Solubility
Soluble in DMSO > 10 mM
Shipping Conditions
Evaluation sample solution: ship with blue ice. All other available size: ship with RT, or blue ice upon request
Download
Download Datasheet